Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

Ibrahim Faruqi, MD, MPH

Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)

Photo of Ibrahim Faruqi

My locations

Active clinical trials

BLISSc-ILD

This study investigates the efficacy and safety of belimumab compared to placebo, in addition to standard therapy, for the treatment of participants with systemic sclerosis associated interstitial lung disease (SSc-ILD). The study will evaluate the…

Investigator
Ibrahim Faruqi
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
RIN-PF-302

Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis.

Investigator
Ibrahim Faruqi
Status
Accepting Candidates
Ages
40 Years - N/A
Sexes
All
TETON

Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.

Investigator
Ibrahim Faruqi
Status
Accepting Candidates
Ages
40 Years - N/A
Sexes
All

My research

Top areas of exploration

  • Anti-Bacterial Agents , 2 publications
  • Disease Progression , 2 publications
  • Pulmonary Embolism , 2 publications
  • Respiratory Distress Syndrome , 2 publications

Research activity

12 publications

126 citations

Why is this important?
View more of Ibrahim Faruqi's research activity

Accepted insurances

Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.

See all insurances

My areas of focus